ALLR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Allarity Therapeutics Inc (ALLR) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows a bearish technical trend, poor financial performance, and lacks positive catalysts or trading signals. Additionally, there is no recent news or influential trading activity to support a bullish case.
The stock has a bearish technical setup with MACD below zero and negatively contracting, RSI at 33.105 in the neutral zone, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support levels are at 0.794 and 0.729, with resistance levels at 0.9 and 1.005. The stock closed at 0.8096, below the pivot point of 0.9, indicating further downside potential.
NULL identified. No recent news, trading signals, or influential trading activity to suggest a positive catalyst.
The stock price dropped significantly (-6.08% during regular market hours and -4.20% post-market). Financial performance is weak, with a YoY net income drop of -76.91% and EPS down -97.54%. The stock has a 30% chance to decline further in the next day, week, and month.
In Q3 2025, revenue remained at 0 with no YoY growth. Net income dropped to -$2,806,000, a -76.91% YoY decline. EPS fell to -0.19, down -97.54% YoY. Gross margin remained at 0 with no improvement.
No analyst ratings or price target changes available.
